Cancer Drug Can Mitigate COVID-19-Induced Organ Damage
A recent study revealed that the cancer drug eganelisib, which contains the PI3K gamma enzyme, can help reduce organ damage caused by severe COVID-19.
A recent study revealed that the cancer drug eganelisib, which contains the PI3K gamma enzyme, can help reduce organ damage caused by severe COVID-19.